Jörg Janne Vehreschild
Jörg Janne Vehreschild
Professor of Digital Medicine und Clinical Data Science, Goethe University Frankfurt, Germany
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group …
OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ...
The Lancet infectious diseases 19 (12), e405-e421, 2019
Severe COVID-19 is marked by a dysregulated myeloid cell compartment
J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ...
Cell 182 (6), 1419-1440. e23, 2020
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ...
The lancet HIV 4 (8), e349-e356, 2017
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...
The Lancet infectious diseases 16 (7), 828-837, 2016
The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
FA Klok, GJAM Boon, S Barco, M Endres, JJM Geelhoed, S Knauss, ...
European Respiratory Journal 56 (1), 2020
Patients at high risk of invasive fungal infections: when and how to treat
MJGT Rüping, JJ Vehreschild, OA Cornely
Drugs 68, 1941-1962, 2008
Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19
JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ...
Immunity 53 (6), 1296-1314. e9, 2020
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals
Y Bar-On, H Gruell, T Schoofs, JA Pai, L Nogueira, AL Butler, K Millard, ...
Nature medicine 24 (11), 1701-1707, 2018
Forty-one recent cases of invasive zygomycosis from a global clinical registry
MJGT Rueping, WJ Heinz, AJ Kindo, V Rickerts, C Lass-Floerl, C Beisel, ...
Journal of Antimicrobial Chemotherapy 65 (2), 296-302, 2010
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
P Koehler, M Stecher, OA Cornely, D Koehler, MJGT Vehreschild, ...
Clinical microbiology and infection 25 (10), 1200-1212, 2019
Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
AJ Ullmann, M Schmidt-Hieber, H Bertz, WJ Heinz, M Kiehl, W Krüger, ...
Annals of hematology 95, 1435-1455, 2016
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for …
OA Cornely, A Böhme, D Buchheidt, H Einsele, WJ Heinz, M Karthaus, ...
haematologica 94 (1), 113, 2009
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German …
WJ Heinz, D Buchheidt, M Christopeit, M von Lilienfeld-Toal, OA Cornely, ...
Annals of hematology 96, 1775-1792, 2017
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19
B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ...
Immunity 54 (11), 2650-2669. e14, 2021
Mucormycosis treated with posaconazole: review of 96 case reports
JJ Vehreschild, A Birtel, MJGT Vehreschild, B Liss, F Farowski, ...
Critical reviews in microbiology 39 (3), 310-324, 2013
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
MM Rüthrich, C Giessen-Jung, S Borgmann, AY Classen, S Dolff, ...
Annals of hematology 100, 383-393, 2021
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in …
BJ Liss, JJ Vehreschild, OA Cornely, M Hallek, G Fätkenheuer, ...
Infection 40, 613-619, 2012
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
JJ Vehreschild, M Rüping, H Wisplinghoff, F Farowski, A Steinbach, ...
Journal of antimicrobial chemotherapy 65 (7), 1466-1471, 2010
Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy
A Trickey, MT May, J Vehreschild, N Obel, MJ Gill, H Crane, C Boesecke, ...
PloS one 11 (8), e0160460, 2016
Severe pneumonia and human bocavirus in adult
B Kupfer, J Vehreschild, O Cornely, R Kaiser, G Plum, S Viazov, ...
Emerging infectious diseases 12 (10), 1614, 2006
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20